BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35192881)

  • 1. A synopsis of modern - day colorectal cancer: Where we stand.
    Ranasinghe R; Mathai M; Zulli A
    Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188699. PubMed ID: 35192881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
    Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
    Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated tumor-to-liver uptake ratio (TLR) from
    Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer.
    Sasaki K; Kawasaki H; Sato M; Koyama K; Yoshimi F; Nagai H
    Dig Surg; 2017; 34(1):60-67. PubMed ID: 27454870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers.
    Odalovic S; Stojiljkovic M; Sobic-Saranovic D; Pandurevic S; Brajkovic L; Milosevic I; Grozdic-Milojevic I; Artiko V
    Neoplasma; 2017; 64(6):954-961. PubMed ID: 28895416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of transmembrane glycoprotein mucin 1 (MUC1) in various types of colorectal cancer and therapies: Current research status and updates.
    Guo M; You C; Dou J
    Biomed Pharmacother; 2018 Nov; 107():1318-1325. PubMed ID: 30257347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of Stage III Colorectal Cancer Patients.
    Fehr M; Müller J; Knitel M; Fornaro J; Horber D; Koeberle D; Cerny T; Güller U
    Clin Colorectal Cancer; 2017 Dec; 16(4):343-348. PubMed ID: 28412138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography for the detection of proximal synchronous lesions in patients with obstructive colorectal cancer.
    Kim WS; Lee HS; Lee JM; Kwak MS; Hwang SW; Park SH; Yang DH; Kim KJ; Myung SJ; Yang SK; Byeon JS
    J Gastroenterol Hepatol; 2017 Feb; 32(2):401-408. PubMed ID: 27418280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal treatment strategies for colorectal liver metastases.
    Birrer DL; Tschuor C; Reiner C; Fritsch R; Pfammatter T; Garcia Schüler H; Pavic M; De Oliveira M; Petrowsky H; Dutkowski P; Oberkofler C; Clavien PA
    Swiss Med Wkly; 2021 Feb; 151():w20390. PubMed ID: 33631027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer: current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation.
    Kekelidze M; D'Errico L; Pansini M; Tyndall A; Hohmann J
    World J Gastroenterol; 2013 Dec; 19(46):8502-14. PubMed ID: 24379567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Technical novelties, latest diagnostic options in the MRI and CT diagnostics of colorectal cancer].
    Jederán É; Gõdény M
    Magy Onkol; 2015 Sep; 59(3):184-92. PubMed ID: 26339907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary nodules and metastases in colorectal cancer.
    Nordholm-Carstensen A
    Dan Med J; 2016 Jan; 63(1):B5190. PubMed ID: 26726908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AGA Clinical Practice Update on Young Adult-Onset Colorectal Cancer Diagnosis and Management: Expert Review.
    Boardman LA; Vilar E; You YN; Samadder J
    Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2415-2424. PubMed ID: 32525015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does
    Jonsson J; Hemmingsson O; Strengbom R; Axelsson J; Riklund K; Nyström H
    Scand J Surg; 2022; 111(1):14574969221083144. PubMed ID: 35348393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synchronous tumors detected with contrast-enhanced F18-FDG positron emission tomography/computed tomography (PET/CTc) in colorectal cancer].
    Ladrón-de-Guevara D; Pérez D; Núñez P; Ramírez F; Zárate A; López F
    Rev Med Chil; 2019 Jul; 147(7):828-835. PubMed ID: 31859980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron Emission Tomography Combined With Computed Tomography vs. No Positron Emission Tomography Combined With Computed Tomography for the Management of Patients With Resectable Colorectal Cancer Liver Metastases and Synchronous Extrahepatic Disease.
    Serrano PE; Gu CS; Moulton CA; Gallinger S
    Am Surg; 2021 Sep; 87(9):1431-1437. PubMed ID: 33345573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association of Helicobacter pylori Seropositivity with All-Cause Mortality among Colorectal Cancer Patients Undergoing PET/CT Scans.
    Shmuely H; Brenner B; Groshar D; Hadari N; Purim O; Nidam M; Eligalashvili M; Yahav J; Bernstine H
    Isr Med Assoc J; 2018 Aug; 20(8):504-508. PubMed ID: 30084577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of colorectal cancer staging with whole-body PET/CT colonography.
    Veit-Haibach P; Kuehle CA; Beyer T; Stergar H; Kuehl H; Schmidt J; Börsch G; Dahmen G; Barkhausen J; Bockisch A; Antoch G
    JAMA; 2006 Dec; 296(21):2590-600. PubMed ID: 17148724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron Emission Tomography-Computed Tomography (PET-CT) Versus No PET-CT in the Management of Potentially Resectable Colorectal Cancer Liver Metastases: Cost Implications of a Randomized Controlled Trial.
    Serrano PE; Gafni A; Gu CS; Gulenchyn KY; Julian JA; Law C; Hendler AL; Moulton CA; Gallinger S; Levine MN
    J Oncol Pract; 2016 Jul; 12(7):e765-74. PubMed ID: 27328792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between 18F-FDG PET/CT Scans and KRAS Mutations in Metastatic Colorectal Cancer.
    Kawada K; Toda K; Nakamoto Y; Iwamoto M; Hatano E; Chen F; Hasegawa S; Togashi K; Date H; Uemoto S; Sakai Y
    J Nucl Med; 2015 Sep; 56(9):1322-7. PubMed ID: 26135109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.